metabolic dysfunction-associated steatotic liver disease (MASLD)

March 10, 2026

Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD

Abstract Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to alterations in liver lipid metabolism, oxidative stress, fibrosis,…

April 30, 2025

Cannabigerol Alleviates Liver Damage in Metabolic Dysfunction-Associated Steatohepatitis Female Mice via Inhibition of Transforming Growth Factor Beta 1

Abstract Background and Aims: Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of metabolic dysfunction-associated steatotic liver disease (MASLD), involves inflammation,…